butyrophenones

Preferred Label : butyrophenones;

MeSH definition : Compounds containing phenyl-1-butanone.;

Wikipedia link : https://en.wikipedia.org/wiki/Butyrophenones;

Is substance : O;

Details

Origin ID

D002090;

UMLS CUI

C0006525;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Butyrophenone [NCIt concept]
- Butyrophenone (substance) [SNOMED CT concept]
Manual BTNT mappings - CISMeF
- Tranquilizer butyrophenone [ICD-11 Extension code]
Record concept(s)
- butyrophenones [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(2-(2-butyryl-3-hydroxyphenoxy)-6-hydroxyphenyl)-3-hydroxybut-2-en-1-one [MeSH Supplementary Concept]
- 1-(4-fluorophenyl)-4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)butan-1-one [MeSH Supplementary Concept]
- 4'-fluoro-alpha-pyrrolidinobutyrophenone [MeSH Supplementary Concept]
- 4'-hydroxymethyl-alpha-pyrrolidinobutyrophenone [MeSH Supplementary Concept]
- 4'-methyl-alpha-pyrrolidinobutyrophenone [MeSH Supplementary Concept]
- 4,4-bis(4-chlorophenyl)-4-hydroxypiperidinobutyrophenone [MeSH Supplementary Concept]
- 4-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluuorophenyl)butan-1-one [MeSH Supplementary Concept]
- 4-(4-(4-diphenylmethoxy-1-piperidyl)butyryl)dimethylphenylacetic acid [MeSH Supplementary Concept]
- 4-fluoro-4(p-nitrophenyl)-2-butanone [MeSH Supplementary Concept]
- 4-fluoro-4-(1,2,3,6-tetrahydro-1,3-dimethyl-2-oxo-6-thionpurin-8-ylthio)butyrophenone [MeSH Supplementary Concept]
- 4-methoxy-alpha-pyrrolidinovalerophenone [MeSH Supplementary Concept]
- 67332MD [MeSH Supplementary Concept]
- CIBA 3315A-Go [MeSH Supplementary Concept]
- CLR151 [MeSH Supplementary Concept]
- N,N-bis(2-(2-butanoyl)-4-nitrophenoxyethyl)-N-(2-chloroethyl)amine [MeSH Supplementary Concept]
- N-(2-(2-butanoyl)-4-nitrophenoxyethyl)-N,N-bis(2-chloroethyl)amine [MeSH Supplementary Concept]
- NSD 2023 [MeSH Supplementary Concept]
- U 35,777A [MeSH Supplementary Concept]
- U-32,802A [MeSH Supplementary Concept]
- acetabutone [MeSH Supplementary Concept]
- azabutyrone [MeSH Supplementary Concept]
- buphedrone [MeSH Supplementary Concept]
- butroxydim [MeSH Supplementary Concept]
- carebastine [MeSH Supplementary Concept]
- carperone [MeSH Supplementary Concept]
- centpyraquin [MeSH Supplementary Concept]
- cloroperone [MeSH Supplementary Concept]
- desacetylsalannobutyrolactone [MeSH Supplementary Concept]
- desaspidin [MeSH Supplementary Concept]
- dihydrolenperone [MeSH Supplementary Concept]
- ebastine [MeSH Supplementary Concept]
- filicin [MeSH Supplementary Concept]
- flavaspidic acid [MeSH Supplementary Concept]
- flavaspidic acid-N-methylglucaminate [MeSH Supplementary Concept]
- fluanisone [MeSH Supplementary Concept]
- hydroxyebastine [MeSH Supplementary Concept]
- hyperjaponol H [MeSH Supplementary Concept]
- hypnorm [MeSH Supplementary Concept]
- itanoxone [MeSH Supplementary Concept]
- ketocaine [MeSH Supplementary Concept]
- lenperone [MeSH Supplementary Concept]
- metylperon [MeSH Supplementary Concept]
- mobenzoxamine [MeSH Supplementary Concept]
- moperone [MeSH Supplementary Concept]
- pipamperone [MeSH Supplementary Concept]
- salannobutyrolactone [MeSH Supplementary Concept]
- timiperone [MeSH Supplementary Concept]
See also
- antipsychotic agents [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Butyrophenone [NCIt concept]
- Butyrophenone (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients